ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $47,753,888 | -0.7% | 3,634,238 | -4.8% | 0.05% | +2.0% |
Q2 2023 | $48,089,853 | +4.2% | 3,816,655 | +7.9% | 0.05% | 0.0% |
Q1 2023 | $46,149,407 | -26.1% | 3,536,353 | -0.1% | 0.05% | -29.0% |
Q4 2022 | $62,460,101 | +32.6% | 3,540,822 | +14.5% | 0.07% | +23.2% |
Q3 2022 | $47,110,000 | -15.8% | 3,093,203 | -18.0% | 0.06% | -15.2% |
Q2 2022 | $55,927,000 | -43.5% | 3,771,199 | -14.2% | 0.07% | -29.0% |
Q1 2022 | $98,999,000 | +58.7% | 4,396,027 | +30.0% | 0.09% | +78.8% |
Q4 2021 | $62,369,000 | +2.7% | 3,380,436 | -25.6% | 0.05% | -5.5% |
Q3 2021 | $60,748,000 | -26.0% | 4,543,669 | +2.4% | 0.06% | -22.5% |
Q2 2021 | $82,122,000 | +10.8% | 4,436,591 | -10.1% | 0.07% | -1.4% |
Q1 2021 | $74,127,000 | +65.5% | 4,936,889 | +59.2% | 0.07% | +80.0% |
Q4 2020 | $44,783,000 | +84.9% | 3,101,302 | +4.2% | 0.04% | +60.0% |
Q3 2020 | $24,225,000 | +11.4% | 2,975,995 | -7.3% | 0.02% | -3.8% |
Q2 2020 | $21,741,000 | +6.5% | 3,211,356 | +10.7% | 0.03% | -18.8% |
Q1 2020 | $20,415,000 | -45.1% | 2,899,810 | -23.5% | 0.03% | -25.6% |
Q4 2019 | $37,202,000 | -6.8% | 3,790,365 | +4.3% | 0.04% | -12.2% |
Q3 2019 | $39,913,000 | -16.2% | 3,635,036 | -11.3% | 0.05% | -16.9% |
Q2 2019 | $47,651,000 | +12.9% | 4,097,220 | -7.4% | 0.06% | +7.3% |
Q1 2019 | $42,214,000 | +29.2% | 4,424,985 | +30.6% | 0.06% | +22.2% |
Q4 2018 | $32,672,000 | -36.5% | 3,389,232 | -6.2% | 0.04% | -27.4% |
Q3 2018 | $51,488,000 | +38.8% | 3,613,237 | +16.9% | 0.06% | +29.2% |
Q2 2018 | $37,094,000 | -1.6% | 3,091,113 | +1.3% | 0.05% | -5.9% |
Q1 2018 | $37,689,000 | -30.8% | 3,051,747 | -18.4% | 0.05% | -32.0% |
Q4 2017 | $54,430,000 | +18.7% | 3,740,896 | +16.1% | 0.08% | +7.1% |
Q3 2017 | $45,867,000 | +98.4% | 3,223,291 | +77.9% | 0.07% | +84.2% |
Q2 2017 | $23,122,000 | -39.0% | 1,812,023 | -39.4% | 0.04% | -43.3% |
Q1 2017 | $37,887,000 | +29.3% | 2,987,931 | +4.1% | 0.07% | +34.0% |
Q4 2016 | $29,292,000 | +4.8% | 2,868,918 | +35.2% | 0.05% | +2.0% |
Q3 2016 | $27,939,000 | -5.8% | 2,121,471 | -9.1% | 0.05% | -10.9% |
Q2 2016 | $29,648,000 | -5.1% | 2,334,526 | -1.2% | 0.06% | -1.8% |
Q1 2016 | $31,225,000 | -18.7% | 2,363,724 | -5.4% | 0.06% | -1.8% |
Q4 2015 | $38,425,000 | +38.3% | 2,498,354 | +11.5% | 0.06% | +39.0% |
Q3 2015 | $27,790,000 | +123.4% | 2,241,167 | +146.5% | 0.04% | +115.8% |
Q2 2015 | $12,439,000 | +208.6% | 909,293 | +169.8% | 0.02% | +216.7% |
Q1 2015 | $4,031,000 | -13.9% | 336,992 | -8.0% | 0.01% | 0.0% |
Q4 2014 | $4,680,000 | -77.6% | 366,479 | -76.5% | 0.01% | -77.8% |
Q3 2014 | $20,919,000 | +11.1% | 1,559,389 | +32.9% | 0.03% | +8.0% |
Q2 2014 | $18,827,000 | +219.8% | 1,173,003 | +259.2% | 0.02% | +212.5% |
Q1 2014 | $5,888,000 | +128.5% | 326,569 | +96.0% | 0.01% | +100.0% |
Q4 2013 | $2,577,000 | -61.5% | 166,658 | -63.0% | 0.00% | -63.6% |
Q3 2013 | $6,702,000 | -17.2% | 450,657 | -27.9% | 0.01% | -26.7% |
Q2 2013 | $8,091,000 | – | 625,261 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Harbour Group | 10,361,438 | $138,999,000 | 5.45% |
HealthCor Management, L.P. | 7,210,000 | $96,722,000 | 4.97% |
Breithorn Capital Management | 328,770 | $4,410,000 | 2.87% |
EMINENCE CAPITAL, LP | 10,206,053 | $136,914,000 | 2.00% |
NOVARE CAPITAL MANAGEMENT LLC | 328,205 | $4,403,000 | 1.08% |
HIGH POINTE CAPITAL MANAGEMENT LLC | 178,550 | $2,395,000 | 1.04% |
Adirondack Research & Management Inc. | 200,749 | $2,693,000 | 1.00% |
GARGOYLE INVESTMENT ADVISOR L.L.C. | 176,727 | $2,371,000 | 0.90% |
Elk Creek Partners, LLC | 251,994 | $3,380,000 | 0.88% |
RS INVESTMENT MANAGEMENT CO LLC | 6,939,494 | $93,093,000 | 0.86% |